Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Baigent

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Annals of Internal Medicine|April 12, 2016
Aspirin for Disease Prevention: Public Policy or Personal Choice?Colin Baigent
The New England Journal of Medicine|May 17, 2021
Pragmatic Trials - Need for ADAPTABLE DesignColin Baigent
BMJ (Clinical Research Ed.)|June 18, 2005
Aspirin for everyone older than 50? AgainstColin Baigent
Journal of the American College of Cardiology|May 30, 2015
Cholesterol metabolism and statin effectiveness in hemodialysis patientsColin Baigent
European Heart Journal|August 26, 2023
Revascularization of low-surgical risk patients with disease of the left main coronary artery: a fresh look at the evidenceColin Baigent, Rafael Sádaba
Nature Reviews. Cardiology|June 28, 2019
Role of aspirin in primary prevention of cardiovascular diseaseCarlo Patrono, Colin Baigent
Journal of the American Society of Nephrology : JASN|January 27, 2018
Should We Increase GFR with Bardoxolone in Alport Syndrome?Colin Baigent, Rachel Lennon
Nature Reviews. Cardiology|May 29, 2010
Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?Carlo Patrono, Colin Baigent
JAMA|September 13, 2007
B vitamins for the prevention of vascular disease: insufficient evidence to justify treatmentColin Baigent, Robert Clarke
Lancet (London, England)|October 17, 2008
Selective COX-2 inhibitors: where do we go from here?Colin Baigent, Carlo Patrono
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Annals of Internal Medicine|April 12, 2016
Aspirin for Disease Prevention: Public Policy or Personal Choice?Colin Baigent
The New England Journal of Medicine|May 17, 2021
Pragmatic Trials - Need for ADAPTABLE DesignColin Baigent
BMJ (Clinical Research Ed.)|June 18, 2005
Aspirin for everyone older than 50? AgainstColin Baigent
Journal of the American College of Cardiology|May 30, 2015
Cholesterol metabolism and statin effectiveness in hemodialysis patientsColin Baigent
European Heart Journal|August 26, 2023
Revascularization of low-surgical risk patients with disease of the left main coronary artery: a fresh look at the evidenceColin Baigent, Rafael Sádaba
Nature Reviews. Cardiology|June 28, 2019
Role of aspirin in primary prevention of cardiovascular diseaseCarlo Patrono, Colin Baigent
Journal of the American Society of Nephrology : JASN|January 27, 2018
Should We Increase GFR with Bardoxolone in Alport Syndrome?Colin Baigent, Rachel Lennon
Nature Reviews. Cardiology|May 29, 2010
Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?Carlo Patrono, Colin Baigent
JAMA|September 13, 2007
B vitamins for the prevention of vascular disease: insufficient evidence to justify treatmentColin Baigent, Robert Clarke
Lancet (London, England)|October 17, 2008
Selective COX-2 inhibitors: where do we go from here?Colin Baigent, Carlo Patrono
Pageof 18